Dr. Haque is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22999 Highway 59 N
Ste 105
Kingwood, TX 77339Phone+1 281-348-8934
Summary
- Current student at College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. Interested in issues at the intersection of public health & medicine including socioeconomic health disparities and healthcare access.
Education & Training
Alfaisal University College of MedicineClass of 2022
Publications & Presentations
Authored Content
- Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among ArabsFebruary 2021
- Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directionsDecember 2020
- The Relationship Between Reactive Oxygen Species and Endothelial Cell MetabolismNovember 2020
- Does the Timing of Surgery after Neoadjuvant Therapy in Breast Cancer Patients Affect the OutcomeJanuary 2020
- Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from 2013 to 2016March 2019
- Abstract: Single institute data to assess timing of surgery post neoadjuvant in breast cancer patientsFebruary 2019
- Efficacy, Safety Profiles and Outcomes of Dual Anti Her2 Blockade in Combination with Neoadjuvant Chemotherapy in Locally Advanced (Stage II-III) Her2 Expressing Breast Cancer Patients, Middle East ExperienceJanuary 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
